Richard A Loukota. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Alendronate/therapeutic useBone Density Conservation Agents/therapeutic useFemaleHip Fractures/etiologyHip Fractures/prevention & controlHumansOsteoporosis/complicationsOsteoporosis/drug therapy
Substances: See more » Bone Density Conservation AgentsAlendronate
Year: 2012 PMID: 22963942 DOI: 10.1136/bmj.e5988
Source DB: PubMed Journal: BMJ ISSN: 0959-8138